|
시장보고서
상품코드
1549984
세계의 소동물 이미징 시장 : 제품(광학 이미징, 핵이미징, 시약), 용도, 지역별 예측(-2032년)Global Small Animal Imaging Market Research Report Information by Product Optical Imaging, Nuclear Imaging, Reagent, by Application, by Region - Forecast to 2032 |
||||||
소동물 이미징 시장 규모는 2022년 11억 2,000만 달러, 2023년 11억 9,000만 달러에서 예측 기간 중 6.87%의 CAGR로 추이하며, 2032년에는 23억 2,000만 달러 규모로 성장할 것으로 예측됩니다.
제약 업계의 R&D비 증가 및 소동물 연구에 대한 의식의 향상이 시장 확대의 원동력이 되고 있습니다.
다양한 방면에서 소동물 연구에 대한 인식이 높아지고 있는 것이 소동물 이미징 산업의 성장에 큰 영향을 미치고 있습니다. 전임상 연구에서 소동물 모델의 중요한 역할을 인식하는 이해관계자들이 늘어나면서 소동물 모델에서 보다 정밀하고 광범위한 조사를 가능하게 하는 첨단 이미징 기술에 대한 수요가 증가하고 있습니다.
또한 연구자들은 질병의 원인을 규명하고, 치료 중재를 평가하고, 임상 결과를 예측하는 데 있으며, 소동물 이미징의 유용성을 인식하고 있으며, 이는 새로운 이미징 기법의 채택을 촉진하고 있습니다. 자금 지원 기관, 정부 및 규제 당국이 소동물 연구 지원의 필요성을 더 잘 인식하게 되면서 투자가 확대되고 규제 환경이 개선되고 있는 것도 이 산업을 촉진하고 있습니다.
지역별 전망
북미 시장이 2022년 가장 높은 점유율을 차지했습니다. 이는 북미의 반려동물 만성질환 유병률 증가와 제약 및 생명공학 R&D 활동이 활발해졌기 때문으로 분석됩니다.
유럽 시장은 두 번째로 높은 점유율을 차지하고 있으며, 제약 및 생명공학 산업의 전임상 이미징 수요 증가, 분자 이미징 R&D에 대한 정부 보조금 증가, 이 지역의 주요 이미징 장비 제조업체의 존재감 등이 주요 요인으로 작용하고 있습니다.
아시아태평양은 2023-2032년까지 크게 증가할 것으로 예상됩니다. 이는 이 지역의 의료비 지출 증가, 신약 개발의 전임상 연구 수요 증가, MRI, CT, PET, SPECT와 같은 이미징 기술 발전으로 인한 것으로 분석됩니다.
세계의 소동물 이미징 시장을 조사했으며, 시장의 정의와 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모 추이·예측, 각종 구분·지역별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
제2장 시장 개요
제3장 조사 방법
제4장 시장 역학
- 촉진요인
- 제약 업계에 의한 R&D 투자의 증가
- 소동물 연구에 대한 의식의 향상
- 억제요인
- 소동물 연구에 관한 엄격한 규제
- 기회
- 전임상 연구를 위한 소동물 이미징 기술의 진보
제5장 시장 요인 분석
- Porter's Five Forces 분석
- COVID-19가 세계의 소동물 이미징 시장에 미치는 영향
제6장 세계의 소동물 이미징 시장 : 제품별
- 영상 진단법
- 시약
제7장 세계의 소동물 이미징 시장 : 용도별
- 약물 치료 프로그램의 모니터링
- 생물 분포 연구
- 암세포 탐지
- 바이오마커
- 종단적 연구
제8장 세계의 소동물 이미징 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제9장 경쟁 구도
- 개요
- 경쟁 벤치마킹
제10장 기업 개요
- BRUKER
- ANALYTIK JENA GMBH+CO. KG
- ASPECT IMAGING LTD.
- MR SOLUTIONS
- FUJIFILM HOLDINGS CORPORATION
- MILABS B.V.
- TRIFOIL IMAGING
- MEDISO LTD.
- LI-COR, INC.
- HESKA CORPORATION
제11장 부록
KSA 24.09.20Global Small Animal Imaging Market Research Report Information by Product Optical Imaging (Photoacoustic Tomography and Optical Coherence Tomography), Nuclear Imaging (Micro PET System, Micro SPECT System, Micro MRI System, Micro CT System, and Others), Reagent (Optical Image Reagent, Contrast Agent, Pet Tracers, and SPECT Probe), by Application (Monitoring Drug Treatment Programme, Bio Distribution Studies, Cancer Cell Detection, Biomarkers, and Longitudinal Studies), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast to 2032
Market Overview
In 2022, the Small Animal Imaging Market is expected to be worth USD 1.12 billion. During the projected period (2023-2032), the small animal imaging market is predicted to increase at a compound annual growth rate (CAGR) of 6.87%, from USD 1.19 billion in 2023 to USD 2.32 billion in 2032. The pharmaceutical industry's increased expenditure in R&D, as well as expanding awareness of small animal research, are driving market expansion.
The increasing awareness of small animal research on a variety of fronts has a substantial impact on the growth of the small animal imaging industry. Initially, demand for sophisticated imaging technologies capable of enabling more precise and extensive studies in small animal models is increasing as more stakeholders recognize the critical role that these models play in preclinical research.
Furthermore, researchers recognize the usefulness of small animal imaging in explaining disease causes, evaluating therapeutic interventions, and predicting clinical outcomes, which is driving the adoption of novel imaging modalities. Furthermore, the industry is being boosted by growing investment and favorable regulatory settings as funding agencies, governments, and regulatory authorities become more conscious of the need of supporting small animal research.
Market segmentation insights
The Small Animal Imaging Market is segmented by product into imaging modality and reagent. Imaging modality is further subdivided into optical imaging and nuclear imaging. Imaging studies are organized into three basic categories: computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography. Additionally, optical imaging is classified into two types: photoacoustic tomography and optical coherence tomography. Nuclear imaging is further classified into five categories: micro-PET systems, micro SPECT systems, micro MRI systems, micro CT systems, and others.
The Small Animal Imaging Market is segmented by application, which includes medication treatment program surveillance, bio distribution studies, cancer cell detection, biomarkers, and long-term research.
Regional Perspectives
In 2022, the North American small animal imaging market had the highest market share. The cause for this is the rising prevalence of chronic diseases in pets in North America, as well as increased research and development activities in medicines and biotechnology.
The second-largest market share in the European small animal imaging market is due to rising demand for preclinical imaging in the pharmaceutical and biotechnology industries, increased government funding for molecular imaging research and development, and the region's strong presence of leading imaging equipment manufacturers.
The Asia-Pacific small animal imaging market is expected to increase significantly between 2023 and 2032. This is due to the region's rising healthcare spending, increased demand for preclinical research in drug discovery and development, and technological advances in imaging modalities such as MRI, CT, PET, and SPECT.
Major Players
The key companies in the Small Animal Imaging Market include Bruker (US), Analytik Jena GmbH+Co. KG (Germany), Aspect Imaging Ltd (US), MR Solutions (UK), FUJIFILM Holdings Corporation (Japan), MILabs B.V. (Netherlands), Trifoil Imaging (US), Mediso Ltd (Hungary), LI-COR, Inc (US), and Heska Corporation (US).
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
- 1.1 OVERVIEW
2 MARKET INTRODUCTION
- 2.1 DEFINITION
- 2.2 SCOPE OF THE STUDY
- 2.3 RESEARCH OBJECTIVE
- 2.4 MARKET STRUCTURE
- 2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
- 3.1 DATA MINING
- 3.2 SECONDARY RESEARCH
- 3.3 PRIMARY RESEARCH
- 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
- 3.5 FORECASTING TECHNIQUES
- 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
- 3.7 DATA TRIANGULATION
- 3.8 VALIDATION
4 MARKET DYNAMICS
- 4.1 OVERVIEW
- 4.2 DRIVERS
- 4.2.1 INCREASING R&D INVESTMENT BY PHARMACEUTICAL INDUSTRY
- 4.2.2 RISING AWARENESS OF SMALL ANIMAL RESEARCH
- 4.3 RESTRAINTS
- 4.3.1 STRICT REGULATIONS GOVERNING ON SMALL ANIMAL RESEARCH
- 4.4 OPPORTUNITIES
- 4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS IN SMALL ANIMAL IMAGING FOR PRECLINICAL STUDIES
5 MARKET FACTOR ANALYSIS
- 5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
- 5.2 IMPACT OF COVID-19 ON THE GLOBAL SMALL ANIMAL IMAGING MARKET
6 GLOBAL SMALL ANIMAL IMAGING MARKET, BY PRODUCT
- 6.1 OVERVIEW
- 6.1.1 IMAGING MODALITY
- 6.1.1.1 OPTICAL IMAGING
- 6.1.1.1.1 PHOTOACOUSTIC TOMOGRAPHY
- 6.1.1.1.2 OPTICAL COHERENCE TOMOGRAPHY
- 6.1.1.2 NUCLEAR IMAGING
- 6.1.1.2.1 MICRO PET SYSTEM
- 6.1.1.2.2 MICRO SPECT SYSTEM
- 6.1.1.2.3 MICRO MRI SYSTEM
- 6.1.1.2.4 MICRO CT SYSTEM
- 6.1.1.2.5 OTHERS
- 6.1.2 REAGENT
- 6.1.2.1 OPTICAL IMAGE REAGENT
- 6.1.2.2 CONTRAST AGENT
- 6.1.2.3 PET TRACERS
- 6.1.2.4 SPECT PROBE
- 6.1.1 IMAGING MODALITY
7 GLOBAL SMALL ANIMAL IMAGING MARKET, BY APPLICATION
- 7.1 OVERVIEW
- 7.1.1 MONITORING DRUG TREATMENT PROGRAMME
- 7.1.2 BIO DISTRIBUTION STUDIES
- 7.1.3 CANCER CELL DETECTION
- 7.1.4 BIOMARKERS
- 7.1.5 LONGITUDINAL STUDIES
8 GLOBAL SMALL ANIMAL IMAGING MARKET, BY REGION
- 8.1 OVERVIEW
- 8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
- 8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 FRANCE
- 8.3.3 UK
- 8.3.4 ITALY
- 8.3.5 SPAIN
- 8.3.6 REST OF EUROPE
- 8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 INDIA
- 8.4.3 JAPAN
- 8.4.4 AUSTRALIA & NEW ZEALAND
- 8.4.5 REST OF ASIA-PACIFIC
- 8.5 REST OF THE WORLD
- 8.5.1 AFRICA
- 8.5.2 MIDDLE EAST
- 8.5.3 LATIN AMERICA
9 COMPETITIVE LANDSCAPE
- 9.1 OVERVIEW
- 9.2 COMPETITIVE BENCHMARKING
10 COMPANY PROFILES
- 10.1 BRUKER
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 PRODUCTS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
- 10.2 ANALYTIK JENA GMBH+CO. KG
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 KEY STRATEGIES
- 10.3 ASPECT IMAGING LTD.
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
- 10.4 MR SOLUTIONS
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 KEY STRATEGIES
- 10.5 FUJIFILM HOLDINGS CORPORATION
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 SWOT ANALYSIS
- 10.5.6 KEY STRATEGIES
- 10.6 MILABS B.V.
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 PRODUCTS OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 SWOT ANALYSIS
- 10.6.6 KEY STRATEGIES
- 10.7 TRIFOIL IMAGING
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT ANALYSIS
- 10.7.6 KEY STRATEGIES
- 10.8 MEDISO LTD.
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 SWOT ANALYSIS
- 10.8.6 KEY STRATEGIES
- 10.9 LI-COR, INC.
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
- 10.10 HESKA CORPORATION
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 PRODUCTS OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES
11 APPENDIX
- 11.1 REFERENCES
- 11.2 RELATED REPORTS
